Lenox Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Lenox Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-44	Closed	-$10K	–	820
2021 Q1	$10K	Hold	44	–	–	﹤0.01%	428
2020 Q4	$5K	Hold	44	–	–	﹤0.01%	519
2020 Q3	$4K	Hold	44	–	–	﹤0.01%	470
2020 Q2	$5K	Sell	44 -76	-63%	-$8.62K	﹤0.01%	446
2020 Q1	$11K	Sell	120 -66	-35%	-$6.99K	﹤0.01%	337
2019 Q4	$19K	Hold	186	–	–	﹤0.01%	348
2019 Q3	$21K	Hold	186	–	–	﹤0.01%	297
2019 Q2	$32K	Hold	186	–	–	0.01%	179
2019 Q1	$31K	Hold	186	–	–	0.01%	169
2018 Q4	$18K	Hold	186	–	–	﹤0.01%	203
2018 Q3	$32K	Hold	186	–	–	0.01%	171
2018 Q2	$26K	Sell	186 -22	-11%	-$3.13K	0.01%	225
2018 Q1	$23K	Buy	208 +164	+373%	+$20.6K	0.01%	256
2017 Q4	$6K	Buy	+44	New	+$5.17K	﹤0.01%	208

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Lenox Wealth Advisors's GWPH Position: Q2 2021 in Review

Lenox Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 44 shares — an estimated $10K sold.

Lenox Wealth Advisors first reported a position in GWPH in Q4 2017 and held it in 14 quarters. The position peaked at $32K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Lenox Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Lenox Wealth Advisors sold 44 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $10K.
Lenox Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 14 quarters.
Lenox Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $32K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Lenox Wealth Advisors's 13F filing for Q2 2021, filed 8 Jul 2021.